The Valley Desk

NCT00112476 · Interventional trial

Temsirolimus and Bryostatin 1 in Treating Patients With Unresectable or Metastatic Solid Tumors

Overall registry status Completed

Phase 1

Conditions Recurrent Melanoma, Recurrent Renal Cell Cancer, Stage IV Melanoma, Stage IV Renal Cell Cancer, Unspecified Adult Solid Tumor, Protocol Specific

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov